Hugo And Russell S Pharmaceutical Microbiology Epz

Pharmaceutical microbiology has a bearing on all aspects of pharmacy, from the manufacture and quality control of pharmaceutical products through to an understanding of the mode of action of antibiotics. Fully revised and restructured, drawing on the contributions of subject experts, and including material relevant to the European curricula in pharmacy, the eighth edition covers: biology of micro-organisms pathogens and host response prescribing therapeutics contamination and infection control pharmaceutical production current trends and new directions Hugo and Russell’s Pharmaceutical Microbiology, a standard text for Schools of Pharmacy for seven editions, continues to be a user-friendly and authoritative guide for both students and practitioners of pharmacy and pharmaceutical microbiology. 'Highly Commended' in the Pharmacology section of the 2012 BMA Book Awards

This publication contains selected papers from the 6th annual European conference, held in Brussels, Belgium in May 2004, which brought together 400 scholars and policymakers from 70 countries involved in international development issues. The conference discussions focused on the progress being made towards the Millennium Development Goals, including examining four key aspects that link developed and developing countries, relating to flows of people, capital, aid and trade.

This report highlights the intrinsic links between poverty, HIV/AIDS, movement for work and globalisation. The negative impact of the epidemic on health and the quality of the labour force, which deters foreign direct investment, is underscored and assessed. The report provides estimates of populations at risk of HIV/AIDS because of the impact of poverty in 34 countries in Sub-Saharan Africa, Asia, Latin America and the Caribbean, and in the more developed regions. It discusses the links between HIV/AIDS and the movement of persons in search of work, in the course of their work, and in the travel and leisure industries; and outlines the changes needed to address and manage the HIV/AIDS epidemic at enterprise, national and global levels.

Kinase drug discovery remains an area of significant interest across academia and in the pharmaceutical industry. There are now around 13 FDA approved small molecule drugs which target kinases and many more compounds in various stages of clinical development. Although there have been a number of reviews/publications on kinase research, this book fills a gap in the literature by considering the current and future opportunities and challenges in targeting this important family of enzymes. The book is forward-looking and identifies a number of hot topics and key areas for kinase drug discovery over the coming years. It includes contributions from highly respected authors with a combined experience in the industry of well over 200 years, which has resulted in a book of great interest to the kinase field and across drug discovery more generally. Readers will gain a real insight into the huge challenges and opportunities which this target class has presented drug discovery scientists. The many chapters cover a wide breadth of topics, are well written and include high quality colour and black and white images. Topics covered include an outline of how medicinal chemistry has been able to specifically exploit this unique target class, along with reflections on the mechanisms of kinases inhibitors. Also covered is resistance to kinase inhibitors caused by amino acid mutations, case studies of kinase programs and reviews areas beyond protein kinases and beyond the human kinome. Also described are modern approaches to finding kinase leads and the book finishes with a reflection of how kinase drug discovery may progress over the coming years.

Essential reading for social and medical scientists and all those interested in infectious diseases and public health, AIDS and the Twenty-First Century examines the social and economic origins and impacts of the HIV/AIDS epidemic. HIV/AIDS is not only a medical problem. It is an indication of the scale of the global crisis in public health. Accessibly written, this book is necessary reading for policymakers, students and all those who are concerned about the relationship between poverty, inequality and infectious diseases.

It is estimated that by the end of 2003 there were just under 38 million people living with HIV/AIDS, with all but two million of these people of working age. This report, prepared by the ILO Programme on HIV/AIDS and the World of Work, sets out global estimates of the impact of HIV/AIDS on the labour force and the working age population in 50 countries in Africa, Asia, Latin America and the Caribbean and in more developed regions. Issues discussed include: the implications for the private and public sectors, on agriculture and concerns for food insecurity and on the informal economy; on women and children; policy implications and examples of responses to the problem in a variety of workplace settings; provision of antiretroviral therapy in conjunction with HIV prevention in the workplace and the potential for expanded access to workplace-based treatment.